-
Antigen study provides a new approach to vaccine development for RSV
europeanpharmaceuticalreview
March 14, 2018
Medical researchers point to a promising route for designing an effective vaccine for the respiratory syncytial virus…
-
Sanofi Pasteur posts 8.3% growth despite 2017 vaccine setbacks
fiercepharma
February 12, 2018
Despite lots of challenges that cropped up during 2017, Sanofi's vaccines outfit grew revenues 8.3% in the year to €5.1 billion ($6.25 billion), helping the drug giant as its pharma segment struggled.
-
Takeda’s Zika Vaccine Candidate Receives U.S. FDA Fast Track Designation
americanpharmaceuticalreview
January 30, 2018
Takeda Pharmaceutical announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to TAK-426, Takeda’s purified, inactivated, alum-adjuvanted, whole Zika virus vaccine candidate.
-
Mother’s antibodies may worsen dengue infection in children
biospectrumasia
January 29, 2018
A dengue vaccine that stimulates a strong T cell response in babies has been found to provide better and broader protection than vaccines which induce the production of mainly antibodies.
-
New vaccine provides universal protection against influenza A, study finds
pharmafile
January 25, 2018
Research led by Georgia State University has enabled the development of a universal vaccine for influenza A viruses, proven to provide long-lasting immunity in mice.
-
Study Shows Superiority of PharmaJet Needle-Free Injector for Poliovirus Vaccine Administration
biospace
January 24, 2018
PharmaJet, the maker of innovative, needle-free injection technology, announced that a study was published in Heliyon Journal showing PharmaJet needle-free injection is superior to needle and syringe for fractional dose poliovirus vaccine campaigns.(1)
-
Fooya! founder in patent war over digital vaccine with US Pharma giant
economictimes.indiatimes
December 27, 2017
Fooya! founder and inventor of 'digital vaccine' technology Bhargav Sri Prakash has run into a trademark war with USD 5-billion pharma giant Moderna Therapeutics.
-
Bangladesh moves to protect Rohingya children from diphtheria
biospectrumasia
December 15, 2017
Accelerated immunization will cover nearly 255 000 children in Ukhiya and Teknaf sub-districts in Cox’s Bazar, while the Government and health partners continue to increase support for diphtheria treatment and prevention
-
Single, high-dose vaccine could provide better protection against cholera outbreaks, new research sh
pharmafile
December 13, 2017
A team at UMSOM has been evaluating the efficacy of a single high-dose live vaccine in the treatment of cholera rather than the traditional two-dose inactivated vaccine approach, hoping to more successfully protect the recent massive outbreak.
-
Gene-based Zika vaccine is safe and induces immune response in healthy adults
worldpharmanews
December 07, 2017
Results from two Phase I clinical trials show that experimental Zika vaccines developed by government scientists at the National Institute of Allergy and Infectious Diseases of the National Institutes of Health are safe and induce immune responses in heal